Peptides DB
Research-centric peptide and protocol reference hub
Study 19 of 24Vasopressin literaturebiorxiv-preprint · Observational2026

Activation of Vasopressin Receptor 1A by Vasopressin Enhances Myometrial Smooth Muscle Cell Excitability by Inhibiting the Potassium Channel SLO2.1

AVP enhances excitability in myometrial smooth muscle cells by inhibiting potassium currents, which may influence uterine contraction dynamics.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the vasopressin corpus
3
Preclinical
18
Observational · this one
1
Open-label
1
Randomised
1
Reviews

Summary and findings

This study investigates the role of arginine vasopressin (AVP) in enhancing the excitability of myometrial smooth muscle cells (MSMCs) through the activation of vasopressin receptor 1A (AVPR1A). The research demonstrates that AVP inhibits SLO2.1-mediated potassium currents, reducing current amplitude to approximately 60% of control currents. The findings suggest a mechanism by which AVP enhances intracellular Ca²⁺ signaling in myometrial cells.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
SLO2.1-mediated potassium currents reduced to approximately 60% of control currents.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Arginine vasopressin (AVP) increases excitability of myometrial smooth muscle cells (MSMCs) through Gαq-coupled AVP receptors. Although excitability requires membrane depolarization, the mechanisms linking AVP receptor activation to membrane depolarization and Ca²⁺ signaling are incompletely understood. Here, we show that AVPR1 is the predominant AVP receptor in primary MSMCs. In Xenopus oocytes, AVP signals through AVPR1 to inhibit SLO2.1-mediated potassium currents, reducing current amplitude to approximately 60% of control currents. Consistent with suppression of a hyperpolarizing conductance, AVP depolarized a myometrial cell line (hTERT-HM) and increased intracellular Ca²⁺ signaling. Analysis of Ca²⁺ dynamics revealed that the initial Ca²⁺ peak was largely preserved under conditions limiting extracellular Ca²⁺ entry, consistent with intracellular store release. Conversely, the oscillatory phase depended on extracellular Ca²⁺ influx and was reduced by SLO2.1 knockdown. Together, these findings support a model in which AVP preferentially signals through AVPR1A to inhibit SLO2.1, depolarize myometrial cells, enhance VDCC-dependent Ca²⁺ entry, and promote excitability, enhancing conditions for uterine contraction.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Vasopressin corpus

CDesign of liquid crystalline nanoparticles: Linking composition to membrane interactions and siRNA delivery.International journal of pharmaceutics: X · 2026 · siRNA delivered by LCN-P407 showed > 1.7-fold greater uptake than that administered by LCN-P188.In vitroCFetal microglia show region-specific and morphology-dependent sex differences in their responsiveness to prenatal maternal stressbiorxiv-preprint · 2026 · Not reported in abstract.AnimalDArginine Therapy for Sickle Cell Disease Acute Pain Episodes: Research Summary.JAMA · 2026reviewDArginine Treatment and Sickle Cell Disease Pain-A Great STArT, but a Hard End Point.JAMA · 2026BArginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.JAMA · 2026HumanCInhibition of the Notch signaling pathway promotes AQP2 plasma membrane accumulation in renal epithelial cells by depolymerizing actin and reducing endocytosisbiorxiv-preprint · 2026 · 60% reduction in clathrin-mediated endocytosis.In vitro